Developing and deploying genomics technologies in support cancer and life sciences research.
Canada's Michael Smith Genome Sciences Centre at BC Cancer (GSC) is an international leader in genomics, bioinformatics and proteomics for precision medicine. By developing and deploying cutting-edge genome sequencing, computational and analytical technology, we are creating novel strategies to prevent and diagnose cancers and other genomic diseases, uncovering new therapeutic targets and helping the world realize the social and economic benefits of genome science.
Translating genome science to help diagnose and treat cancers and other diseases
The GSC fosters close collaborations between scientists and clinicians, allowing for direct translational research. Through the Personalized OncoGenomics (POG) program, the GSC deploys whole genome sequencing technology to influence therapeutic and management strategies for late-stage cancer patients in real time. The GSC is also accredited through the College of American Pathologists to perform clinical genomic panel testing.
BC Premier John Horgan visits the GSC
Ahead of our 20th Anniversary, we gave the Premier of British Columbia a hands-on tour of our DNA sequencing and bioinformatics technology platform.
The Honourable John Horgan received a personal tour of the our DNA sequencing and bioinformatics technology platform from our director and distinguished scientist, Dr. Marco Marra.
Read full story.